ALLMedicine™ Keratoacanthoma Center

Feb 14th, 2021 - Non-melanoma skin cancer (NMSC), predominantly squamous cell carcinoma and basal cell carcinoma, is increasing worldwide. Dermatoscopy, which is one of the non-invasive diagnostic techniques, is important for early diagnosis of NMSC. To determine ...

Feb 11th, 2021 - Xeroderma pigmentosum (XP) is a rare genodermatosis with a propensity to develop malignant skin tumors lifelong. In this retrospective study, 24 XP patients were evaluated with regard to frequency and clinicopathological features of benign and mal...

Feb 1st, 2021 - An exciting recent approach to targeting transcription factors in cancer is to block formation of oncogenic complexes. We investigated whether interfering with the interaction of the transcription factor SALL4, which is critical for leukemic cell ...

Jan 4th, 2021 - Keratoacanthoma (KA) is a cutaneous tumor with a biphasic pattern of growth. A rapidly growing phase is usually followed by involution. KA occurs on sun-damaged skin. There are many listed causative associations, which include some therapeutic age...

Oct 8th, 2020 - Intralesional methotrexate (il-MTX) has been reported as a useful therapy in keratoacanthoma (KA) and cutaneous squamous cell carcinoma (cSCC). However, the data available on the histological changes induced by this therapy are very scarce. We con...

Feb 14th, 2021 - Non-melanoma skin cancer (NMSC), predominantly squamous cell carcinoma and basal cell carcinoma, is increasing worldwide. Dermatoscopy, which is one of the non-invasive diagnostic techniques, is important for early diagnosis of NMSC. To determine ...

Feb 11th, 2021 - Xeroderma pigmentosum (XP) is a rare genodermatosis with a propensity to develop malignant skin tumors lifelong. In this retrospective study, 24 XP patients were evaluated with regard to frequency and clinicopathological features of benign and mal...

Feb 1st, 2021 - An exciting recent approach to targeting transcription factors in cancer is to block formation of oncogenic complexes. We investigated whether interfering with the interaction of the transcription factor SALL4, which is critical for leukemic cell ...

Jan 4th, 2021 - Keratoacanthoma (KA) is a cutaneous tumor with a biphasic pattern of growth. A rapidly growing phase is usually followed by involution. KA occurs on sun-damaged skin. There are many listed causative associations, which include some therapeutic age...

Oct 8th, 2020 - Intralesional methotrexate (il-MTX) has been reported as a useful therapy in keratoacanthoma (KA) and cutaneous squamous cell carcinoma (cSCC). However, the data available on the histological changes induced by this therapy are very scarce. We con...

Oct 24th, 2019 - To the Editor: Keratoacanthoma (KA)–type squamous cell carcinomas (SCCs) are rapidly evolving neoplasms of the epithelium that often spontaneously regress but rarely metastasize. 1,2 Keratoacanthomas are thought to ascend from the hair follicle,1 a.

May 17th, 2019 - It is important to note that there have been no studies directly comparing the efficacy of the 3 approved BRAF/MEK inhibitor combinations, but the 3 different regimens have some differences in their toxicity profiles (Table 2). Of note, single-age.

Apr 5th, 2018 - Comment Spontaneous regression is not unique to MCC, as this phenomenon also has been reported in keratoacanthoma, lymphoma, basal cell carcinoma, and melanoma. 15 Complete spontaneous regression is defined as occurring in the absence of therapy th.

May 18th, 2017 - DISCUSSION The pathology report shows a low-grade, well-differentiated squamous cell carcinoma (SCC)—in this case, a keratoacanthoma (KA). This common form of SCC is usually found on the sun-exposed skin of older patients.

Apr 3rd, 2015 - To the Editor: A 61-year-old man with a medical history of type 2 diabetes mellitus presented to us with a 2. 5×3.